Investors

Novo A/S

Novo A/S

http://www.novo.dk

Novo A/S is a Copenhagen-based company founded in 1999.

Recent Investments

Orbis Medicines
( 44 )
Seed

Draupnir Bio
( 41 )
Seed

Asceneuron
( 48 )
Series C

Adcendo
( 37 )
Series A

CIRCTEC
( 60 )
Series C

Asgard Therapeutics
( 41 )
Series A

Commit Biologics
( 48 )
Seed

Myricx Bio
( 75 )
Series A

HepaRegeniX
( 48 )
Series C

Reduced
( 44 )
Seed

LimmaTech Biologics
( 33 )
Series A

HPNow
( 41 )
Series A

NMD Pharma
( 48 )
Series B

Hoba Therapeutics
( 48 )
Series A

Bactolife
( 44 )
Series A

AMSilk
( 48 )
Series C

Engimmune Therapeutics
( 33 )
Seed

Roslin Technologies
( 37 )
Unknown

F2G
( 63 )
Unknown

Breye Therapeutics
( 18 )
Unknown

Precirix
( 52 )
Series B

NMD Pharma
( 48 )
Unknown

F2G
( 63 )
Unknown

NorthSea Therapeutics
( 56 )
Series C

Muna Therapeutics
( 52 )
Series A

Hemab
( 52 )
Series A

BioPhero
( 37 )
Series A

Orbis Medicines
( 44 )
Unknown

NorthSea Therapeutics
( 56 )
Series B

ReViral
( 52 )
Series C

Sundew
( 22 )
Seed

Rappta Therapeutics
( 37 )
Series A

The Protein Brewery
( 41 )
Series A

Hemab
( 52 )
Unknown

IO Biotech
( 52 )
Unknown

STipe Therapeutics
( 41 )
Series A

InProTher
( 37 )
Unknown

NMD Pharma
( 48 )
Series A

NorthSea Therapeutics
( 56 )
Series A

AFYX Therapeutics
( 41 )
Series A

Hoba Therapeutics
( 48 )
Seed

Acesion Pharma
( 48 )
Series A

NMD Pharma
( 48 )
Seed

MinervaX
( 56 )
Seed

Acesion Pharma
( 48 )
Seed